The International Maritime Organization (IMO) has announced the enhancement of its data reference model within the IMO Compendium on Facilitation and Electronic Business. It follows the recent 49 th ...

THE Nigerian Ports Authority, NPA, and the International Maritime Organization, IMO, are currently working out modalities for an electronic port data exchange programme aimed at developing an ...

When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising partners may have about you. Choose “Customize or Reject all” if you want ...

Shipping Fuel Transparency Will Lower Emissions and Cut Costs. NGOs call on shipping industry regulator to drive down costs, trigger improved fuel efficiency and reduce ship GHG emissions through ...

The International Maritime Organisation’s (IMO) decision to postpone the adoption of its proposed Net Zero Framework has sent ripples through the shipping and energy markets, with analysts warning ...

IMO Health's recognition in the data analytics category highlights its ability to transform disorganized, incomplete clinical data into actionable insights. By standardizing data with 99% accuracy and ...

The data presented at AAI demonstrate that inhibition of TLR7, 8 and 9 with IMO-8400 suppressed the cycle between autoimmune antibody production and tissue damage, leading to improved renal function ...

The Director General of the Nigerian Maritime Administration and Safety Agency, Dr Dayo Mobereola, has said that critical records regarding the agency domiciled with the International Maritime ...

CAMBRIDGE, Mass -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), today announced preliminary data from the first part of a Phase 2 clinical study conducted by the Company of IMO-2055 monotherapy in ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that data from its Phase 1 clinical trial of IMO-2125, its novel immune modulator for the treatment of ...

Idera Pharmaceuticals Announces Presentation of Preclinical Data of IMO-8400 in Both Lupus and Psoriasis Models Data to Be Presented at American Association of Immunologists Meeting 2012 May 01, 2012 ...